Dr. Peng Zhang 张鹏
Chief Physician, Associate Professor
Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and management of cancer of unknown primary, lung cancer, breast cancer, esophageal cancer, thymoma, and other mediastinal tumors. Expertise in precision molecular targeted therapy and tumor immunotherapy.
Dr. Zhang is a Chief Physician and Associate Professor at Tongji Hospital. A graduate of Peking Union Medical College, Dr. Zhang completed state-sponsored advanced study in the United States in 2017. Dr. Zhang holds five national and Ministry of Education research projects and one PCT international patent for an immunotherapy target.
Professional roles
- Youth Committee Member, Tumor Radiotherapy Professional Committee, Wu Jieping Medical Foundation
- Member, Chinese Society for Immunology
- Committee Member, Immunotherapy Expert Committee, Hubei Clinical Oncology Society
Name order: in Chinese the family name comes first (Zhang Peng). Papers usually list the name as Peng Zhang or Zhang P.
Selected publications
123 papers on PubMed matched by name and affiliation; 23 as first or senior author since 2016. Most recent first- or senior-author papers:
- iScience, 2026 (senior author): Glucose forecasting and hypoglycemia forewarning in type 1 and type 2 diabetes using deep learning. PubMed 41907406
- Patterns (N Y), 2026 (senior author): Hierarchical fusion of electrocardiogram and phonocardiogram data improves heart failure detection. PubMed 42028404
- Exp Mol Med, 2025 (senior author): Fas apoptotic inhibitor molecule 2 mitigates metabolic dysfunction-associated fatty liver disease through autophagic CRTC2 degradation. PubMed 41057543
- Front Nutr, 2025 (senior author): Mechanisms of the effect of gut microbes on depression through the microbiota-gut-brain axis. PubMed 40843192
- Med, 2025 (first author): Clinician-artificial intelligence collaboration: A win-win solution for efficiency and reliability in atrial fibrillation diagnosis. PubMed 40220757
- J Cell Mol Med, 2024 (senior author): Role of AT-rich interaction domain 1A in gastric cancer immunotherapy: Preclinical and clinical perspectives. PubMed 38041544
- Cancer Med, 2024 (senior author): The association of genomic alterations with PD-L1 expression in Chinese patients with EGFR/ALK wild-type lung adenocarcinoma and potential predictive value of Hippo pathway mutations to immunotherapy. PubMed 38396367
- Cancers (Basel), 2023 (senior author): Susceptibility Genes Associated with Multiple Primary Cancers. PubMed 38136334
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion